WO1999051214A3 - Progestogen-only contraceptive kit - Google Patents

Progestogen-only contraceptive kit Download PDF

Info

Publication number
WO1999051214A3
WO1999051214A3 PCT/EP1999/002338 EP9902338W WO9951214A3 WO 1999051214 A3 WO1999051214 A3 WO 1999051214A3 EP 9902338 W EP9902338 W EP 9902338W WO 9951214 A3 WO9951214 A3 WO 9951214A3
Authority
WO
WIPO (PCT)
Prior art keywords
progestogen
contraceptive
days
contraceptive kit
phase
Prior art date
Application number
PCT/EP1999/002338
Other languages
French (fr)
Other versions
WO1999051214A2 (en
Inventor
Elisabeth Wilhelmina M Vromans
Andre Groenewegen
Gerardus Herman Vitus Korver
Petrus Gustaaf Wilhelm Stokman
Original Assignee
Akzo Nobel Nv
Elisabeth Wilhelmina M Vromans
Andre Groenewegen
Gerardus Herman Vitus Korver
Petrus Gustaaf Wilhelm Stokman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv, Elisabeth Wilhelmina M Vromans, Andre Groenewegen, Gerardus Herman Vitus Korver, Petrus Gustaaf Wilhelm Stokman filed Critical Akzo Nobel Nv
Priority to AU41345/99A priority Critical patent/AU4134599A/en
Publication of WO1999051214A2 publication Critical patent/WO1999051214A2/en
Publication of WO1999051214A3 publication Critical patent/WO1999051214A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Abstract

Disclosed is a contraceptive regimen of the progestogen-only type. Good cycle-control and contraceptive efficacy is obtained by providing a progestogen phase of 21-25 days and a placebo or pill-free phase of 1-7 days. The daily dosage of the progestogen is in an amount sufficient to achieve contraceptive working on the basis of ovulation inhibition.
PCT/EP1999/002338 1998-04-07 1999-04-07 Progestogen-only contraceptive kit WO1999051214A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU41345/99A AU4134599A (en) 1998-04-07 1999-04-07 Progestogen-only contraceptive kit

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98201096 1998-04-07
EP98201096.9 1998-04-07

Publications (2)

Publication Number Publication Date
WO1999051214A2 WO1999051214A2 (en) 1999-10-14
WO1999051214A3 true WO1999051214A3 (en) 2000-05-11

Family

ID=8233572

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1999/002338 WO1999051214A2 (en) 1998-04-07 1999-04-07 Progestogen-only contraceptive kit

Country Status (2)

Country Link
AU (1) AU4134599A (en)
WO (1) WO1999051214A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6978894B2 (en) 1999-12-20 2005-12-27 Merck & Co., Inc. Blister package for pharmaceutical treatment card
AU2270101A (en) 1999-12-20 2001-07-03 Merck & Co., Inc. Pharmaceutical kit
US20040188316A1 (en) 2003-03-26 2004-09-30 The Procter & Gamble Company Kit for pharmaceutical use
JP5288796B2 (en) * 2004-07-07 2013-09-11 ワイス・エルエルシー Periodic progestin regimens and kits
DE102008036825A1 (en) * 2008-08-05 2010-02-11 Aicuris Gmbh & Co. Kg Pregnancy prevention by progestagens
US8752704B2 (en) 2010-12-17 2014-06-17 The Procter & Gamble Company Blister cards promoting intuitive dosing

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1965881A1 (en) * 1969-10-09 1971-04-29 Merck Patent Gmbh Contraceptive gestagens of limited adminis- - tration
GB1304239A (en) * 1969-10-09 1973-01-24
FR2223018A1 (en) * 1973-03-26 1974-10-25 Ortho Pharma Corp
US4018919A (en) * 1975-07-16 1977-04-19 Eli Lilly And Company Sequential contraceptive method using two types of progestational agents
US4171358A (en) * 1974-04-19 1979-10-16 Eli Lilly And Company Novel contraceptive method
EP0491443A1 (en) * 1990-12-17 1992-06-24 Akzo Nobel N.V. Progestagen-only contraceptive
WO1999045886A2 (en) * 1998-03-09 1999-09-16 Akzo Nobel N.V. New contraceptive kit for monotherapy

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1965881A1 (en) * 1969-10-09 1971-04-29 Merck Patent Gmbh Contraceptive gestagens of limited adminis- - tration
GB1304239A (en) * 1969-10-09 1973-01-24
FR2223018A1 (en) * 1973-03-26 1974-10-25 Ortho Pharma Corp
US4171358A (en) * 1974-04-19 1979-10-16 Eli Lilly And Company Novel contraceptive method
US4018919A (en) * 1975-07-16 1977-04-19 Eli Lilly And Company Sequential contraceptive method using two types of progestational agents
EP0491443A1 (en) * 1990-12-17 1992-06-24 Akzo Nobel N.V. Progestagen-only contraceptive
WO1999045886A2 (en) * 1998-03-09 1999-09-16 Akzo Nobel N.V. New contraceptive kit for monotherapy

Also Published As

Publication number Publication date
WO1999051214A2 (en) 1999-10-14
AU4134599A (en) 1999-10-25

Similar Documents

Publication Publication Date Title
AU645382B2 (en) Low estrogen oral contraceptives
EP0402950A3 (en) Treatment of postmenopausal disorders
CA2356747A1 (en) Triphasic oral contraceptive
AU3436097A (en) Progestogen-anti-progestogen regimens
CA2264960A1 (en) External formulation containing loxoprofen
WO1998055080A3 (en) Leave-on antimicrobial compositions
MY128337A (en) New combination of steroids
CA2233457A1 (en) Pharmaceutical angiostatic dipeptide compositions and methods of use thereof
NZ333750A (en) Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen
WO1997023228A3 (en) Contraceptive process and kit for female mammals, comprising a combination of gestagen and oestrogen
CA2057714A1 (en) Progestagen-only contraceptive
EP1079790A4 (en) Broad spectrum microbicidal and spermicidal compositions, devices, and methods
BG103325A (en) Analgetic preparation for external application
RS51434B (en) Multi-phase contraceptive preparation based on a natural estrogen
WO1999051214A3 (en) Progestogen-only contraceptive kit
GR1002907B (en) Coated trimeboutine maleate tablet
WO1997006807A3 (en) Contraceptive combined preparation, kits containing the same and contraceptive method using this combined preparation
AU3256499A (en) Use of a compound inhibiting the activity of a sodium channel and a calcium channel in a composition for topical use
WO1999025360A3 (en) Progestogen-antiprogestogen regimens
WO2001051055A3 (en) Pharmaceutical compositions containing steroidal structures and uses thereof
UA43337C2 (en) Hormonal means for treating the blackheads
CA2330217A1 (en) Therapeutic agent for a cancer and method of screening the same and health-care auxiliary food
AU7928500A (en) Connection piece
CA2157590A1 (en) Use of terbinafine for the therapeutic treatment of pneumocystosis
AU4650899A (en) Kit of drug-containing preparation to be prepared before using and resolvent therefor

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AU BA BB BG BR CA CN CU CZ EE GE HU ID IL IN IS JP KP KR LC LK LR LT LV MG MK MN MX NO NZ PL RO RU SG SI SK SL TR TT UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AU BA BB BG BR CA CN CU CZ EE GE HU ID IL IN IS JP KP KR LC LK LR LT LV MG MK MN MX NO NZ PL RO RU SG SI SK SL TR TT UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

NENP Non-entry into the national phase

Ref country code: KR

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA